Metacross Otw
Payments companies reported to CMS as associated with Metacross Otw. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Metacross Otw, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Metacross Otw
These are the largest totals companies reported as associated with Metacross Otw. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Srinivasa Potluri | Plano, TX | Interventional Cardiology | $19,800.00 |
| Christopher Brown | Seattle, WA | Interventional Cardiology | $8,545.70 |
| Claudia Serrano-Gomez | New York, NY | Interventional Cardiology | $5,896.59 |
| Rhian Davies | York, PA | Cardiovascular Disease | $5,721.71 |
| Jaikirshan Khatri | New York, NY | Interventional Cardiology | $2,890.52 |
| Manish Parikh | New York, NY | Surgery | $1,929.63 |
| Subhash Banerjee | Dallas, TX | Cardiovascular Disease | $1,765.65 |
| Edvard Skripochnik | Bronx, NY | Vascular Surgery | $1,508.55 |
| Elise Anderson | Charleston, WV | Interventional Cardiology | $1,429.54 |
| Allen Jeremias | E Setauket, NY | Cardiovascular Disease | $821.36 |
Prescribed Metacross Otw?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.